Clearside Biomedical Inc (FRA:CLM)
€ 0.885 0.065 (7.93%) Market Cap: 69.14 Mil Enterprise Value: 47.25 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 67/100

Clearside Biomedical Inc at JPMorgan Healthcare Conference Transcript

Jan 16, 2020 / 07:30PM GMT
Release Date Price: €2.14 (+0.94%)
Matthew Alexander Bannon
JP Morgan Chase & Co, Research Division - Analyst

All right. Welcome back to the 38th JPMorgan Annual Healthcare Conference. My name is Matt Bannon. I'm one of the junior analysts here at JPMorgan. I'm happy to introduce our next presenting company, Clearside Biomedical, and presenting on behalf of the company is Chief Medical Officer, Tom Ciulla. Tom?

Thomas A. Ciulla
Clearside Biomedical, Inc. - Chief Medical Officer

Well, thank you. Once again, I'm Tom Ciulla, Chief Medical Officer. And as a retina specialist, I'm thrilled to be part of a potential paradigm shift in the way we treat retinal diseases.

I may make some forward-looking statements during this presentation, which are summarized in this slide and all our filings are online.

We have a versatile therapeutic platform with the SCS Microinjector with proprietary drug formulations that target the suprachoroidal space. We're basically focused on small molecules and gene therapies to develop an internal research and development pipeline and external

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot